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Evaluation of a Comprehensive Diabetes Disease
Management Program: Progress in the Struggle for
Sustained Behavior Change
JANICE CLARKE, R.N., B.B.A., ALBERT CRAWFORD, Ph.D., 
and DAVID B. NASH, M.D., M.B.A.
ABSTRACT
The successful management of diabetes with a goal of achieving near-normoglycemia requires
patients to make multiple lifestyle changes as part of an intensive, complex, and coordinated
therapeutic regimen aimed at reducing the risk of complications associated with the disease.
The difficulty in creating and sustaining these lifestyle behavior changes is a major stum-
bling block in achieving the desired therapeutic goal. An underlying assumption of compre-
hensive disease management is that regular, personal contact with nurses and ancillary health
professionals will facilitate these lifestyle behavior changes for program participants. The re-
sults of a survey of self-reported data from 750 participants in a comprehensive diabetes man-
agement program, reported on here, show strong perceptions of positive behavior change over
the broad range of medical and lifestyle treatment areas associated with effective manage-
ment of diabetes. These results suggest that diabetes disease management programs are an
effective approach to helping diabetic patients accomplish the lifestyle behaviors critical to
their health.
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INTRODUCTION
CHRONIC DISEASES such as diabetes, asthma,coronary artery disease, and hypertension
have replaced acute and infectious diseases as
the major cause of death and disability in the
United States. According to statistics reported
by the Institute on Health and Aging, chronic
diseases affect over 100 million Americans and
account for 75% of national health care costs.
Among chronic diseases, diabetes may be the
“poster child,” with its broad-ranging com-
plexity and costliness, in both human and fi-
nancial terms. Increasingly common and dis-
turbingly under-diagnosed, diabetes affects
nearly 16 million U.S. individuals and contrib-
utes to almost 200,000 deaths per year.1 Total
direct and indirect costs attributed to diabetes
in the United States approach $105 billion per
year.2 As the population continues to age, so
the prevalence and the costs of diabetes are ex-
pected to rise. Recent studies project a rise of
at least 15% by the year 2010 and 60% by 2050.3
For people with diabetes, adhering to rec-
ommended treatment regimens has never been
simple; but in recent years it has become a for-
midable challenge. Based on compelling evi-
dence from two landmark studies, the Diabetes
Office of Health Policy and Clinical Outcomes, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Control and Complications Trial (DCCT) and
the United Kingdom Prospective Diabetes
Study (UKPDS),4,5 the current treatment goal
for people with diabetes has escalated from
mere blood glucose control to near-normo-
glycemia. The DCCT and UKPDS studies dem-
onstrated the importance of optimal glucose
control in reducing the risk, or delaying the
progression, of serious complications of the
disease for both type 1 (insulin dependent) and
type 2 patients. With near normoglycemia as
the new “gold standard,” the ongoing care and
treatment strategies recommended by the
American Diabetes Association (ADA) have in-
tensified.6 More frequent monitoring and sus-
tained adherence to medication, diet, and ex-
ercise regimens are typically required to
achieve the desired level of glycemic control. It
follows that providing optimal treatment
makes greater demands of the primary care
provider—and achieving the best outcomes
places increased burdens on the diabetic pa-
tient, physician, and health care system alike.
Diabetes is one of the most psychologically
and behaviorally demanding of the chronic
medical illnesses.7 The outcome of diabetes
treatment is highly dependent on the self-care
behavior of the patient. It is estimated that pa-
tients are expected to conduct 95% of their own
diabetes management.8 Patients with diabetes
are expected to make multiple lifestyle changes
simultaneously. The complexity involved in
achieving optimal control requires almost “fa-
natic-like” behavior from the patient with dia-
betes as he or she strives to understand the ef-
fect of exercise, medications, dietary intake,
and stress on blood glucose levels. Moreover,
the self-management process is not static—pa-
tients must learn to understand the complex
physiological changes in their bodies and to in-
corporate these changes into their self-man-
agement decisions.9
Failure to sustain desired behaviors is asso-
ciated with a high risk of complications, but pa-
tients with diabetes often do not fully under-
stand their illness, take their medication
correctly, or make lifestyle changes recom-
mended by their physicians. Further, they of-
ten lack the emotional support necessary for
coping with their condition.10
Collaborative relationships between health
care providers and their patients with diabetes
may be the most important element in improv-
ing patient adherence and outcomes.8 How-
ever, for time-pressed primary care providers
who manage the clinical care of most of these
patients, the demands for medical care, moni-
toring, social and emotional support, education
and reeducation required by this complex, pro-
gressive disease are often overwhelming. Sta-
tistics reported by the U.S. Department of
Health and Human Services (DHHS) in 2000
suggest that medical care for diabetes as cur-
rently practiced in the United States neither
meets the ADA guidelines nor approaches the
levels of the treatment groups documented in
the DCCT or UKPDS.15 While a variety of rea-
sons are generally offered for this, perhaps the
most valid explanation is the lack of an inte-
grated, coordinated care management system
designed to support both the patient and the
physician in creating and sustaining the desired
self-management behaviors across the entire
health care delivery spectrum.
Contributions of behavioral science and 
diabetes education
Nonadherence to medication regimens is a
major problem in all therapeutic areas, ranging
from 30% to 60%, with the higher rates occur-
ring in symptom-free patients.11 As noted by
Glasgow et al. in their review of behavioral sci-
ence contributions,12 other studies have found
that, while adherence to medication regimens
is a problem, compliance is poorest in the ar-
eas involving other lifestyle modifications such
as dietary change and home glucose monitor-
ing.
Behavioral science has developed theories
and provided frameworks for understanding
and studying nonadherence and its determi-
nants. The Health Belief Model (HBM), for in-
stance, recognizes and explains the relationship
between perceived health benefits and a pa-
tient’s success with self-care. The Transtheo-
retical Model described by Prochaska et al. de-
fines behavior change as occurring in five
distinct stages: precontemplation, contempla-
tion, preparation, action, and maintenance.13
While a theoretical model, it is particularly use-
ful in diabetes education in that it recognizes
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behavior change as a continuum and identifies
success in terms of progress toward change as
well as in terms of a realized outcome of the
change.
The field of diabetes education has also pro-
duced insights into diabetes patient behavior
change and “self-efficacy.” The concept of “pa-
tient empowerment” has been applied to dia-
betes education to ensure that the choices made
by patients living with diabetes are informed
choices. Studies suggest that patient empower-
ment is an effective approach to developing ed-
ucational interventions for addressing the psy-
chosocial aspects of the disease and, by
implication, that it is conducive to improving
blood glucose control.14
The translation of these behavioral concepts
into practice requires systems and resources
designed to support both patients and physi-
cians in actualizing the behavior changes iden-
tified as critical success factors for effective self-
management.
Disease management as an approach for creating
and sustaining positive behavior change
Patient success in adhering to healthcare reg-
imens requiring changes in behavior and
lifestyle is associated with rapport with health
care professionals who play a role in engen-
dering optimism, maintaining enthusiasm, and
facilitating and encouraging maintenance of
health behaviors.10 Traditional strategies have
focused on diabetes education classes with cer-
tified diabetes educators and nutritionists, and
diabetes education assistance in physicians’ of-
fices, often provided as outreach by teaching
hospitals. The ADA has advocated a physician-
coordinated team approach to diabetes care
management. These teams might include
nurses, nutritionists and behavioral health pro-
fessionals with expertise in diabetes care and
treatment. There is considerable evidence that
these traditional educational approaches have
positive effects on outcomes. However, these
approaches would be difficult to apply to large
numbers of patients with diabetes simultane-
ously. They do not offer promise as a resolu-
tion to the national delivery system problems
underlying the DHHS findings cited above.
Over the past decade, disease management
programs have emerged as a framework for
supporting interventions to effect positive be-
havior changes in patients with chronic ill-
nesses, particularly diabetes. Disease manage-
ment is generally defined as “a system of
coordinated healthcare interventions and com-
munications for populations with conditions in
which patient self-care efforts are significant”
(DMAA Definition of Disease Management).
Focusing on both clinical and non-clinical in-
terventions, disease management programs ad-
dress a disease or condition in a manner that
maximizes effectiveness and efficiency regard-
less of treatment settings or customary reim-
bursement methods. The overriding goal is to
prevent acute exacerbation of the disease and
the accompanying use of expensive resources
by emphasizing prevention, proactive care
management and effective integration and co-
ordination of care processes across the provider
spectrum.16 Through this approach, disease
management programs help patients and their
physicians to better adhere to the recognized
standards of care and prevent avoidable uti-
lization of health care resources.
Proponents of disease management believe
that, when effectively designed and imple-
mented, it offers substantial promise to im-
prove health outcomes, thereby reducing over-
all costs. The disease management model shifts
the focus from “utilization management” (i.e.,
targeting the sickest and/or highest risk pa-
tients) to a population-based approach involv-
ing identification and stratification of all pa-
tients diagnosed with a particular disease. In
combination with the structures of modern
health plans, the disease management model
presents a powerful opportunity for improving
upon the traditional model for managing dia-
betes. Existing health plan structures incorpo-
rate the requisite range of healthcare providers
and services, provide operational and infor-
mational tools to support positive change, and
are the repository for the data necessary to
manage change.
On a national level, the Institute of Medicine
(IOM) has recognized the enormous potential
of the disease management model. In “Cross-
ing the Quality Chasm: A New Health System
for the 21st Century,” the IOM calls for the ex-
pansion of disease management services for
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chronic illnesses as an integral part of a
smoothly functioning healthcare system.
American Healthways (AMHC): description of
the Diabetes HealthwaysSM program
American Healthways, a recognized leader
in the field of disease management and the
largest publicly traded disease management or-
ganization in the nation, has successfully part-
nered with health plans to enhance the care of
their members with chronic diseases. AMHC’s
disease-specific “Healthways” programs offer
a broad scope of services and components from
which a health plan may tailor a program to its
unique member population and provider net-
work. A distinctive feature of the Diabetes
HealthwaysSM program is that once a patient
is identified and participating, the program co-
ordinates all of the patient’s health care needs.
In providing support to patients, whether or
not their needs are related to diabetes, the pro-
gram effectively treats the person rather than
the disease.
In 2000, AMHC contracted to provide a com-
prehensive diabetes disease management pro-
gram for a health plan serving approximately
800,000 members over a statewide area in the
midwestern United States. Under the terms of
this agreement, AMHC provided its Diabetes
HealthwaysSM program to the plan’s “risk” and
“Medicare 1 Choice” members diagnosed
with diabetes who did not opt-out of partici-
pation. (Note: The “opt-out” rate for this plan
was 3%.)
AMHC’s programs are provided on an “en-
gagement” basis to all of the health plan’s sub-
scribers identified as having diabetes through
retrospective review of pharmaceutical and
other medical claims; that is, all identified dia-
betics are automatically enrolled rather than in-
vited to enroll. Once identified and enrolled,
diabetic members are classified according to
AMHC’s proprietary, four-tiered population
stratification model to assure that members re-
ceive the appropriate frequency and intensity
of interventions. The strata range from the
healthiest group (stratum 1), currently show-
ing no indicators for meaningful risk of health
compromise, to the highest risk group (stratum
4), with severe health and/or behavior prob-
lems adversely affecting their health status. The
initial stratification incorporates behavioral
data provided by the member and the primary
physician in addition to health status informa-
tion and utilization patterns provided by the
health plan. The stratification model is dy-
namic, allowing for changes based on new data
and the member’s changing health status.
The AMHC Diabetes HealthwaysSM pro-
gram is based on American Diabetes Associa-
tion Guidelines and features ADA Standards of
Care in its core content. The program protocol
for all participants, regardless of stratification
level, includes mailed letters of introduction
and welcome kits; scheduled outbound “Care
Calls” as well as a “hot line” for inbound mem-
ber calls; and periodic “reminder card” and
newsletter mailings. The program provides
parallel communications—for example, intro-
ductory letter and welcome kit, Standard of
Care notices—with the members’ primary care
physicians. An electronic database equipped
with proprietary software enables AMHC per-
sonnel to track program participants’ medical
claims, drug prescriptions, nature and fre-
quency of laboratory tests and, in most cases,
laboratory test results.
The core of the program is the “Care Call,”
an outbound personal communication between
a specially trained nurse and the patient. Care
Calls are regularly scheduled telephonic inter-
actions between AMHC’s nurses and program
participants. Each call may include, but is not
limited to: diabetes education, including iden-
tification of knowledge deficits; establishment
of and progress in meeting self-care goals; re-
view of adherence to medication regimen and
the primary physician’s treatment plan; review
of specific problems and interventions initiated
to address those issues; identification of new
problems the member is experiencing; and re-
minders about standards of care. Typically,
Care Calls reinforce positive behaviors such as
taking medications as prescribed, adhering to
appointment schedules, and doing or getting
appropriate medical tests. AMHC’s nurses also
discuss diabetes-specific preventive measures,
stress factors and, if relevant, smoking cessa-
tion and alcoholic beverage consumption. On
an annual basis, the nurses administer a Gen-
eral Health Assessment, a Depression Risk As-
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sessment Screening, and a Quality of Life 
Survey for each program participant. The fre-
quency of scheduled Care Calls ranges from
quarterly to daily according to stratification
level and individual patient needs.
For participants in all but the lowest risk stra-
tum (asymptomatic), the program features the
formation of a documented self-care goal
agreement focused on defining a plan for pos-
itive behavior change. This is accomplished
telephonically, and is supplemented by a series
of scheduled Care Calls providing individual-
ized education, advocacy and physician treat-
ment plan support. On an acute basis, calls fo-
cus on problem-specific assessments and
problem-specific interventions. The intensity
and frequency of calls follows the proprietary
stratification protocol. Communication of crit-
ical information or “alert values” to physicians
is made as appropriate.
Central to the effectiveness of the Care Call
is the development and maintenance of trust-
ing relationships between AMHC’s nurses and
the program participants. It is hypothesized
that these regularly occurring, personal con-
tacts with the nurses (and other ancillary health
professionals who make up the patient’s
AMHC care team) help patients to manage
their diets, achieve blood glucose and choles-
terol targets, and in general facilitate the be-
haviors necessary for reducing the incidence of,
or retarding the development of, complica-
tions.
An overriding goal of AMHC’s Diabetes
HealthwaysSM program is to reinforce the pos-
itive behaviors, attitudes, skills, and knowl-
edge of its participants. Patient adherence to
medical treatment regimens, and the requisite
lifestyle modifications, is expected to bring
about the desired clinical outcomes, and, as a
result, the desired financial outcomes. Aggre-
gate clinical process and cost data indicate that
the program is achieving these objectives.
MATERIALS AND METHODS
Evaluation of the overall impact of the Dia-
betes HealthwaysSM program typically in-
cludes clinical quality process and objective
outcome measures, member and physician sat-
isfaction measures and financial measures. Be-
cause patient behavior change is so critical to
the success of a diabetes management program,
AMHC undertook a study to assess the pres-
ence and extent of positive behavior changes in
enrolled diabetes patients as part of its overall
process for regular and comprehensive pro-
gram quality evaluations.
Study design, population, and sampling rationale
As illustrated in Table 1, a five-group, pro-
portionally allocated, random sampling design
was employed to quantify the extent to which
program participants perceived that their be-
haviors changed since enrolling in the pro-
gram.
The sample was drawn from the entire eli-
gible population in order to obtain a statisti-
cally valid set of responses representative of
that population. To be included in the study,
diabetes members (i.e., members with dia-
betes as their primary medical condition,
without any evidence of congestive heart fail-
ure) must have been documented as continu-
ously enrolled between the initial date of
member eligibility and the study population
creation date (10/31/2001), and must have re-
ceived a minimum of one Care Call. To en-
sure appropriate representation of all inter-
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TABLE 1. PROPORTIONAL ALLOCATION OF STUDY POPULATION
Group No. of care calls Population No. of completed surveys
1 1–2 Care Calls 431 149
2 2–3 Care Calls 430 150
3 3–6 Care Calls 430 149
4 6–8 Care Calls 430 149
5 Over 8 Care Calls 430 151
Total 2,151 748
vention levels in the study, members meeting
study inclusion criteria were arrayed from
least to most Care Calls, providing the basis
for the five groupings. From this ordering,
members were divided into five proportion-
ally allocated groups. Further, members
within each group were randomized to en-
sure that the final sample would accurately
represent the population from which it was
drawn.
Survey instrument and method of administration
The survey instrument, a 10-item question-
naire with a four-point rating scale (plus a “not
applicable/don’t know” rating), was devel-
oped by AMHC’s Informatics Department. The
questions were designed to elicit participant
perceptions regarding changes in their behav-
ior in the key areas addressed, that is, eating
habits, taking medications and recommended
tests, attending to test results, stopping/reduc-
ing smoking and drinking, increasing physical
activity, increasing use of preventive health
services, and reducing stress. The survey was
administered telephonically by an unaffiliated,
independent market research organization that
provided training on appropriate interview
techniques to its staff. Survey calls were mon-
itored and completed surveys were reviewed
at random by supervisory staff. In order to as-
sure equal representation across the five
groups, approximately 150 surveys were com-
pleted per group (Table 1).
Survey inclusion criteria
To be eligible for inclusion in the study,
members were required to meet the following
minimum qualifications: documented as being
continuously enrolled in the disease manage-
ment program from the program’s inception
date or from the date of eligibility; 18 years of
age or older as of 10/31/2001; having a valid
telephone number; and having a minimum of
one successfully completed Care Call.
RESULTS
A total of 1,720 telephone calls were at-
tempted in order to complete a total of 748 sur-
veys (a 43% success rate). There were no sig-
nificant age or gender effects—the average age
of respondents was 59 years and 386 (51%) re-
spondents were female. Forty-one percent (305)
of respondents received a “high number” (six
or more) of Care Calls, and 59% (447) received
a “low number” of Care Calls (less than six).
The average number of Care Calls received per
respondent was 5.18. When viewed by risk
stratification level, the respondent group
closely reflected the distribution of the total
program population: 24 (3%) in stratum 1; 299
(40%) in stratum 2; 354 (47%) in stratum 3; and
75 (10%) in stratum 4. Likewise, the age distri-
bution for survey respondents was similar to
that of the population: 87 (11%) at 18–44 years
of age; 396 (54%) at 45–64 years of age; and, 262
(35%) greater than 64 years of age.
Table 2 contains the frequency distribution
of responses by question. As illustrated, the to-
tal perceived behavior change (i.e., all re-
sponses of “somewhat,” “moderately,” and “a
lot”) ranged from a low of 65.2% on question
5 (“stopped or reduced smoking”) to a high of
93.9% on question 7 (“improved on taking rec-
ommended medical tests”). Total responses to
question 5 (“stopped or reduced smoking”)
and question 6 (“stopped or reduced drink-
ing”) suggest that relatively few of these pro-
gram participants were preintervention smok-
ers and/or drinkers. “Not applicable” was the
answer given by 62% (544) of the respondents
for question 5 and by 74% (594) of the respon-
dents for question 6. Disregarding questions 5
and 6, over 87% of the total responses for the
other eight questions support the assertion that
participation in the AMHC Diabetes Health-
waysSM program effects favorable behavioral
change.
A general linear model (GLM) was devel-
oped to examine the effects of risk stratifica-
tion levels and Care Calls on perceived be-
havior change indicators. Table 3 shows mean
scores for each survey question (excluding
question 5 and question 6) by Care Call fre-
quency group, including statistical controls
for the effects of Risk Stratification Level. For
example, respondents receiving one to five
Care Calls had a mean perceived improve-
ment in eating habits of 3.26 (where the num-
ber “3” represents the response “moderately”
and the number “4” represents the response
“a lot”), while those respondents receiving six
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or more Care Calls had a mean perceived im-
provement of 3.47.
Where significant, the effects of Care Calls
on behavior change indicators when control-
ling for risk stratum are shown. Both the risk
stratum and the number of Care Calls appear
to have an effect on perceived behavior
change.
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TABLE 2. FREQUENCY DISTRIBUTIONS: BEHAVIOR CHANGE INDICATORS
Indicator/ Total
survey behavior
question Not at all Somewhat Moderately A lot changea
1. Improved eating 95 352 160 90 602
habits 13.63% 50.50% 22.96% 12.91% 86.37%
2. Improved taking 105 256 175 172 603
medications 14.8% 36.16% 24.72% 24.29% 85.17%
3. Increased physical 111 324 196 89 609
activity 15.42% 45.00% 27.22% 12.36% 84.58%
4. Increased discussion 86 271 237 144 652
about medical 11.65% 36.72% 32.11% 19.51% 88.34%
condition
5. Stopped or reduced 72 58 47 30 135
smoking 34.78% 28.02% 22.71% 14.49% 65.22%
6. Stopped or reduced 40 56 39 21 116
drinking 25.64% 35.90% 25.00% 13.46% 74.36%
7. Improved on taking 45 250 279 159 688
recommended medical 6.14% 34.11% 38.06% 21.69% 93.86%
tests
8. Paid closer attention 46 220 232 242 694
to medical results 6.22% 29.73% 31.35% 32.70% 93.78%
9. Increased use of 80 260 242 155 657
preventive health 10.85% 35.28% 32.84% 21.03% 89.15%
services
10. Spent less time 131 273 197 111 581
worrying about 18.40% 38.34% 27.67% 15.59% 81.60%
condition
aTotal behavior change is the sum of the values of "somewhat," "moderately," and "a lot."
TABLE 3. GENERAL LINEAR MODELa RESULTS: PERCEIVED BEHAVIOR CHANGE MEAN SCORE BY
NUMBER OF CARE CALLS, CONTROLLING FOR AGE GROUP, GENDER, AND RISK STRATUM
BCI: 1–5 BCI: 61
Indicator/survey questionb care calls care calls F, p
1. Improved eating habits 3.26 3.47 F 5 5.85
p , 0.05
2. Improved taking medications 3.58 3.59 p 5 n.s.
3. Increased physical activity 3.36 3.37 p 5 n.s.
4. Increased discussion about medical 3.50 3.73 F 5 8.11
condition p , 0.01
7. Improved on taking recommended 3.68 3.86 F 5 5.58
medical tests p , 0.05
8. Paid closer attention to medical results 3.81 4.04 F 5 8.93
p , 0.01
9. Increased use of preventive health 3.60 3.70 p 5 n.s.
services
10. Spent less time worrying about 3.35 4.49 p 5 n.s.
condition
aSAS PROC GLM for unbalanced analysis of variance (ANOVA) designs.
bQuestions 5 and 6 (reducing smoking and drinking) were excluded from these analyses.
The survey findings are even more persua-
sive when viewed in combination with clinical
process outcomes for the program. More than
93% of survey respondents reported improve-
ment in taking recommended medical tests. As
shown in Table 4, there were dramatic, pro-
gram-wide increases in testing for HbA1c, LDL
cholesterol, diabetic retinopathy and microal-
buminuria for the enrolled diabetic population
during the first year of the Diabetes Health-
waysSM program.
Of further interest are the results of a cost
analysis for the program. In the relatively
short-term (the first year of the program), costs
for program participants (i.e., total population
of members with diabetes, with or without
CHF) decreased from an adjusted baseline of
$559.44 PM/PM (1999) to $503.07 PM/PM for
the study period, a 10.1% reduction. For the
same period, costs for the nondiabetes mem-
bers in this health plan increased by 21.2%.
DISCUSSION
The Care Call component of the Diabetes
HealthwaysSM program focuses on improving
participants’ understanding of their disease
and the crucial importance of adhering to the
recognized standards of care while providing
support in helping them to change their be-
haviors and lifestyles to accommodate the in-
tensive treatment regimens. The findings of
this survey of perceived behavior change in
program participants are uniformly positive,
strongly so in a majority of the areas empha-
sized by the Diabetes HealthwaysSM program.
It is recognized that self-reported measures
must be viewed with some caution. For exam-
ple, a recent study examining the relationship
between actual Hb A1c test rates and various
self-reported measures of health status found
substantial differences between the patients’
perceptions of health status and satisfaction
with care and the actual medical care they re-
ceived.17 Nevertheless, the findings of this sur-
vey show a strong correlation between per-
ceived behavior change and actual outcomes,
suggesting a high probability of causality.
It is impossible to establish absolute causal-
ity when dealing with a complex, multifaceted
program for a disease such as diabetes. In ad-
dition to internal programmatic factors, exter-
nal factors ranging from the increase in public
awareness of diabetes to the involvement of the
National Committee on Quality Assurance
(NCQA) in monitoring diabetes treatment
(HEDIS standards reporting requirements) in-
troduce variables of indeterminate impact on
the behavior of participants in disease man-
agement programs.
An obvious weakness in the study is the lack
of a clinical outcomes measure, i.e. a change in
the HbA1c test results for the study population.
However, behavioral scientists such as
Sanazaro and Williamson make a strong case
that, while not a direct measure of improve-
ment or deterioration in health status, compli-
ance may be influenced by and/or result from
a health care intervention, leading to improved
outcomes.18 They make a convincing case for
“compliance” as a valuable process outcome.
Some have defined compliance as an “inter-
mediate outcome” which is useful in evaluat-
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TABLE 4. CHANGES IN CLINICAL QUALITY PROCESS MEASURES FOR MEMBERS
ENROLLED IN DIABETES DISEASE MANAGEMENT PROGRAM
Baseline (1999), n 5 2,982
Process measure Number (%) Number (%) Chi-square value
At least 1 HbA1c 1,581 (53.0) 2,441 (77.6) 2,175 (p , 0.001)a
At least 2 HbA1c 755 (25.3) 1,547 (49.2) 1,065 (p , 0.001)a
LDL 1,056 (35.4) 1,980 (63.0) 1,600 (p , 0.001)a
DRE 523 (17.5) 735 (23.4) 201 (p , 0.001)a
Microalb. 399 (23.4) 993 (31.6) 570 (p , 0.001)a
aCritical value of p 5 0.001: 10.827.
First year (6/00–5/01), n 5 3,144
ing the means by which a disease management
program can improve outcomes. Self-reported
or objective measures of adherence/compli-
ance are included in this definition.
Specific characteristics of a population dra-
matically affect behaviors, perceptions and out-
comes. The subjects in this study were mem-
bers of a commercial health plan in the
southwestern United States. A multicultural,
northeastern, urban population may have very
different motivators and responses than the
population represented in the study. Given
previous geographically dispersed outcomes
reported for other health plans using AMHC’s
Diabetes HealthwaysSM programs, we suspect
that the results found in the population stud-
ied are likely to be similar in other populations.
CONCLUSION
Comprehensive patient-centered diabetes
management programs, focused on providing
proactive, personal support for patients with
diabetes, hold promise for ending the struggle
to create and sustain patient behavior change.
Results of a survey of 750 participants in a Di-
abetes HealthwaysSM diabetes disease man-
agement program show strong evidence of per-
ceived positive behavior change in ten critical
treatment areas. When viewed in combination
with positive clinical process outcomes and re-
duced PMPM costs for the entire program,
these findings are even more compelling. While
the survey does not prove any causal linkages
as a result of the Diabetes HealthwaysSM pro-
gram, it does demonstrate that the perceived
changes were not the result of random chance.
Absent any other significant factors, it is rea-
sonable to conclude that the program was a pri-
mary contributor to both the perceived and re-
ported results.
Increasingly, behavioral scientists are recog-
nizing diabetes treatment as predominantly be-
havioral, that is, promoting self-management.12
There is ample evidence in the health behavior
literature of a growing acceptance of behavior
change as an outcome—or “intermediate out-
come”—on its own merits. In evaluating the
performance of a multifaceted disease man-
agement program such as Diabetes Health-
waysSM, a measure of behavior change is valu-
able, particularly when viewed in combination
with improvement in patients’ health status
and satisfaction as well as in terms of cost sav-
ings.
In “Crossing the Quality Chasm,” the Insti-
tute of Medicine (IOM) recognized the pivotal
role of ongoing management of chronic illness
in a smoothly functioning healthcare system
and called for expansion of disease manage-
ment services.19 The IOM has also called for ad-
ditional research into appropriate outcome
measures for gauging the success of disease
management programs. Progress is being made
in developing universally accepted definitions
of the attributes of disease management pro-
grams such as optimal program delivery (e.g.,
means of identification, engagement versus en-
rollment, telephone versus on-line), compo-
nents, and outcomes reporting. The Disease
Management Association of America (DMAA)
has published an industry standard definition
and is embarking on an effort to develop an in-
dustry standard outcomes reporting method-
ology. Other organizations such as the National
Committee on Quality Assurance (NCQA) and
the Disease Management Advisory Council
(DMAC) are making headway on accreditation
and evaluation programs for disease manage-
ment.
Validated and peer-reviewed large-scale out-
comes studies from comprehensive diabetes
disease management programs are beginning
to appear regularly in the literature. The sum
impact of these studies is strongly positive in
demonstrating the effectiveness of these pro-
grams in helping participants to make and sus-
tain the behavior changes necessary for im-
proving their health status while reducing
costs.
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